Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | BCHE | P06276 | 4/20 | 0.61 |
| ▸ | ACE | P12821 | 3/20 | 0.60 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | APAF1 | O14727 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.57 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.57 |
| ▸ | ITGAL | P20701 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | CCKBR | P32239 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848569 | 1.00 | MEN1 (0.63) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL3848966 | 1.00 | MEN1 (0.63) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL6244061 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL6244059 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL6245120 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL28377319 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL6245123 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL8384762 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| SCHEMBL8384759 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE | |
| Water SCHEMBL27944928 | 0.99 | MEN1 (0.62) | MEN1KMT2AALOX15BCHEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112920092-B | Prodrugs of glutamine analogues | 约翰霍普金斯大学 | 2024-04-26 | — | — | CN | claimed |
| US-20220233502-A1 | COMPOSITION FOR PREVENTING OR TREATING ASTHMA, RHINITIS OR CONJUNCTIVITIS, COMPRISING N-ACYL AMINO ACID AS ACTIVE INGREDIENT | STEMDR INC. (KR) | 2022-07-28 | — | — | US | claimed |
| CN-114340612-A | Composition for preventing or treating asthma, rhinitis or conjunctivitis comprising N-acylamino acid as active ingredient | 斯特姆德公司 | 2022-04-12 | — | — | CN | claimed |
| EP-3977990-A1 | COMPOSITION FOR PREVENTING OR TREATING ASTHMA, RHINITIS OR CONJUNCTIVITIS, COMPRISING N-ACYL AMINO ACID AS ACTIVE INGREDIENT | Stemdr Inc. (KR) | 2022-04-06 | — | — | EP | claimed |
| WO-2020242133-A1 | COMPOSITION FOR PREVENTING OR TREATING ASTHMA, RHINITIS OR CONJUNCTIVITIS, COMPRISING N-ACYL AMINO ACID AS ACTIVE INGREDIENT | 전북대학교 산학협력단 | 2020-12-03 | — | — | WO | claimed |
| CN-111971037-A | Compositions comprising N-acetyl or N-acyl amino acids for the treatment of atopy or pruritis | 斯特姆德公司 | 2020-11-20 | — | — | CN | claimed |
| US-20200316001-A1 | COMPOSITION FOR TREATING ATOPY OR PRURITUS CONTAINING N-ACETYL OR N-ACYLAMINO ACID | STEMDR INC. (KR) | 2020-10-08 | — | — | US | claimed |
| EP-3714880-A2 | COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID | Stemdr Inc. (KR) | 2020-09-30 | — | — | EP | claimed |
| CN-110831584-A | Targeted drug rescue with novel compositions, combinations and methods thereof | 埃克塞瓦有限责任公司 | 2020-02-21 | — | — | CN | claimed |
| WO-2013155511-A1 | DELIVERY OF PRESERVATIVES BY FOOD PACKAGING | NEVADA NATURALS INC. (US) | 2013-10-17 | — | — | WO | claimed |
| US-20130231389-A1 | Delivery Of Preservatives By Food Packaging | Nevada Naturals, Inc. (US) | 2013-09-05 | — | — | US | claimed |
| EP-1435388-B1 | D-aminoacylase mutants from Alcaligenes denitrificans for improved D-amino acid production. | DAICEL CORP (JP) | 2012-12-12 | — | — | EP | claimed |
| US-20040197880-A1 | D-aminoacylase mutants | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-10-07 | — | — | US | claimed |
| EP-1435388-A2 | D-aminoacylase mutants from Alcaligenes denitrificans for improved D-amino acid production. | Daicel Chemical Industries, Ltd. (JP) | 2004-07-07 | — | — | EP | claimed |
| US-6664083-B2 | Adjusting stereospecificiy of amino acid seqences; obtain sample polypeptides, incubate with enzyme, recover stereospecific compound | DAICHEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-12-16 | — | — | US | claimed |
| US-6437175-B2 | MILD REACTION CONDITIONS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 2002-08-20 | — | — | US | claimed |
| US-20020102662-A1 | Methods for racemizing N-acylamino acids and producing optically active amino acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-01 | — | — | US | claimed |
| EP-1130108-A1 | Methods for racemizing N-acylamino acids and producing optically active amino acids | Daicel Chemical Industries, Ltd. (JP) | 2001-09-05 | — | — | EP | claimed |
| US-5892112-A | ACYLATION OF AMINO ACIDS WITH ANHYDRIDES OR CARBOXY GROUPS, AMIDATION WITH AMINE AND CONVERSION OF ACID OR ESTER TO HYDROXAMIC ACID AND HYDROLYSIS | GLYCOMED INCORPORATED (US) | 1999-04-06 | — | — | US | claimed |
| US-4085207-A | AND AT LEAST ONE OF N-ACYL-L-TRYPTOPHANS AND N-ACYL-L-PROLINES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JA) | 1978-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197880-A1 | D-aminoacylase mutants | DAO, IL4I1, DDC | MEN1 4296/4885KMT2A 782/4885ALOX15 1148/4885 |
| US-20200316001-A1 | COMPOSITION FOR TREATING ATOPY OR PRURITUS CONTAINING N-ACETYL OR N-ACYLAMINO ACID | NAT1, AADAT, AANAT | MEN1 4326/4885KMT2A 308/4885ALOX15 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.